EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessment of Vitamin D Metabolism Disorders in Hemodialysis Patients

Maksymilian Hryciuk iD, Zbigniew Heleniak iD, Sylwia Małgorzewicz iD, Konrad Kowalski, Jędrzej Antosiewicz, Anna Koelmer, Michał Żmijewski iD, Alicja Dębska-Ślizień iD

Nutrients · 2025

DOI: 10.3390/nu17050774 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Maksymilian Hryciuk und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Medical University of Gdańsk, Dębinki 7 Street, 80-211 Gdańsk, Poland. Hauptthemen laut MEDLINE: Renal Dialysis, Vitamin D Deficiency, Vitamin D, Kidney Failure, Chronic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Knowledge Grant funded this research from the National Science Centre, Poland, Medical University of Gdansk.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with end-stage chronic diseases, especially those undergoing hemodialysis (HD), often experience mineral bone disease (MBD), leading to hypocalcemia, hyperphosphatemia, and elevated parathyroid hormone (PTH). Vitamin D deficiency and metabolism disorders are also common, resulting from impaired conversion of 25(OH)D3 to its active form, 1,25(OH)2D3, and reduced inactivation to 24,25(OH)2D3. This study aimed to assess the levels of 25(OH)D2, 25(OH)D3, 24,25(OH)2D3, 3-epi-25(OH)D3, and the vitamin D metabolism ratio (VMR) in patients with maintenance HD.

Methods

A cross-sectional study was conducted on 66 HD patients (22–90 years, average 61.3 ± 16.4), with a control group of 206 adults without chronic kidney disease (CKD), both without cholecalciferol supplementation. Results: the HD patients had significantly lower 25(OH)D3 levels (15 ng/mL vs. 22 ng/mL) and higher deficiency rates (69% vs. 39%) compared to the controls. However, both groups showed similarly low levels of optimal vitamin D3. The HD patients had lower 24,25(OH)D3 levels (0.1 vs. 2.1 ng/mL) and a lower VMR (0.9% vs. 9%). 3-epi-25(OH)D3 levels and its ratio to 25(OH)D3 were significantly lower in the HD group. Alphacalcidol supplementation raised 1,25(OH)2D3 levels (30.4 vs. 16.2 pg/mL) without affecting other vitamin D metabolites. The HD patients had higher levels of 25(OH)D2 compared to the controls (0.61 vs. 0.31 ng/mL).

Conclusions

Vitamin D3 reserves are lower, and both functional deficiency and impaired catabolism of vitamin D3 are present in HD patients compared to the general population. The VMR index is the most sensitive parameter for vitamin D3 deficiency assessment, highlighting the importance of measuring 24,25(OH)D3. Alphacalcidol supplementation increases 1,25(OH)2D3 levels without affecting other vitamin D metabolites. 25(OH)D2 is the only metabolite that was higher in HD patients than the controls.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisVitamin D DeficiencyVitamin DKidney Failure, ChronicHumansMiddle AgedMaleFemaleCross-Sectional StudiesAgedAdultAged, 80 and overYoung Adult

Stichwörter der Autor:innen

1,25(OH)2D324,25(OH)2D325(OH)D225(OH)D33-epi-25(OH)D3alphacalcidiolchronic kidney diseasehemodialysisvitamin Dvitamin D metabolite ratio

Substanzen

Vitamin D

Autor:innen und Institutionen

  • Department of Nephrology, Medical University of Gdańsk, Dębinki 7 Street, 80-211 Gdańsk, Poland.
  • Department of Clinical Nutrition, Medical University of Gdańsk, Dębinki 7 Street, 80-211 Gdańsk, Poland.
  • Department of Bioenergetics and Exercise Physiology, Medical University of Gdańsk, Dębinki 1 Street, 80-211 Gdańsk, Poland.
  • Masdiag Laboratory, S. Żeromskiego 33 Street, 01-882 Warsaw, Poland.
  • Centre of Biostatistics and Bioinformatics Analysis, Medical University of Gdańsk, 1a Dębinki, 80-211 Gdańsk, Poland.
  • Department of Histology, Medical University of Gdańsk, Dębinki 1 Street, 80-211 Gdańsk, Poland.

ORCID-Profile: Maksymilian Hryciuk, Zbigniew Heleniak, Sylwia Małgorzewicz, Michał Żmijewski, Alicja Dębska-Ślizień

Förderung

  • Knowledge Grant funded this research from the National Science Centre, Poland
  • Medical University of Gdansk

Zitieren

APA

Hryciuk, M., Heleniak, Z., Małgorzewicz, S., Kowalski, K., Antosiewicz, J., Koelmer, A., Żmijewski, M., & Dębska-Ślizień, A. (2025). Assessment of Vitamin D Metabolism Disorders in Hemodialysis Patients. Nutrients. https://doi.org/10.3390/nu17050774

Vancouver

Hryciuk M, Heleniak Z, Małgorzewicz S, Kowalski K, Antosiewicz J, Koelmer A, et al. Assessment of Vitamin D Metabolism Disorders in Hemodialysis Patients. Nutrients. 2025. doi:10.3390/nu17050774

BibTeX
@article{Hryciuk2025,
  author = {Hryciuk, Maksymilian and Heleniak, Zbigniew and Małgorzewicz, Sylwia and Kowalski, Konrad and Antosiewicz, Jędrzej and Koelmer, Anna and Żmijewski, Michał and Dębska-Ślizień, Alicja},
  title = {Assessment of Vitamin D Metabolism Disorders in Hemodialysis Patients},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17050774}
}
Kostenlos starten →